Related Experiment Video
Updated: Oct 29, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
A Multistress Model for High Throughput Screening Against Nonreplicating Mycobacterium tuberculosis.
Ben Gold1, Thulasi Warrier2, Carl Nathan3
1Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA. bsg2001@med.cornell.edu.
Developing models of nonreplicating Mycobacterium tuberculosis is key for discovering new drugs. This study presents a novel multistress model for high-throughput screening to find compounds effective against persistent tuberculosis infections.
Area of Science:
- Microbiology
- Drug Discovery
- Tuberculosis Research
Background:
- Persistent Mycobacterium tuberculosis (M. tuberculosis) poses a significant challenge in treating tuberculosis.
- Conventional antimycobacterial drugs are primarily effective against replicating bacteria, leading to phenotypic resistance in nonreplicating states.
- Understanding the biology of nonreplicating M. tuberculosis is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To develop and describe a novel multistress model for inducing nonreplication in M. tuberculosis.
- To adapt this model for high-throughput screening (HTS) to identify potential drug candidates.
- To investigate pathways essential for M. tuberculosis survival during nonreplicating states.
Main Methods:
- The study employed a multistress model simulating host microenvironmental conditions.
- Conditions included acidic pH, mild hypoxia, nitric oxide flux, and reactive nitrogen intermediates.
- A fatty acid (butyrate) was used as a carbon source at low concentrations.
Main Results:
- The described model successfully induced a nonreplicating state in M. tuberculosis.
- This model is suitable for high-throughput screening (HTS) applications.
- The model mimics relevant host conditions for studying persistent M. tuberculosis.
Conclusions:
- The developed multistress model provides a valuable platform for HTS against nonreplicating M. tuberculosis.
- This approach can lead to the discovery of tool compounds targeting persistent bacterial survival.
- The findings may facilitate the development of new drugs to overcome phenotypic resistance in tuberculosis treatment.
More Related Videos
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
15:28A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
Published on: January 17, 2014